Showing results (21-30 of 259) with videos related to

Sort By:
Pageof 26
Nuclear Medicine Communications|June 29, 2002
Uptake of cis-4-[18 F]fluoro-L-proline in scar formation: a marker of collagen synthesis?M Zimny, B Klosterhalfen, J Conze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumorsK J Langen, A R Börner, V Müller-Mattheis, et al.
Nuclear Medicine and Biology|April 27, 2001
Whole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-prolineA R Börner, K J Langen, H Herzog, et al.
Journal of Neural Transmission. General Section|January 1, 1991
Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidolH Karbe, K Wienhard, K Hamacher, et al.
Nuklearmedizin. Nuclear Medicine|September 13, 2002
Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortemF Forutan, S Estalji, M Beu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1992
Noninvasive assessment of regional cardiac adenosine using positron emission tomographyA Deussen, M Henrich, K Hamacher, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2005
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumoursM Weckesser, K J Langen, C H Rickert, et al.
Nuklearmedizin. Nuclear Medicine|September 15, 2001
Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorderR Larisch, A Klimke, F Mayoral, et al.
Pageof 26